Body contouring,
after the weight is off.
The editorial atlas for body contouring after GLP-1 medication or bariatric surgery — tummy tucks, lower body lifts, Ozempic face, skin tightening. Plain English, every cost figure and clinical claim sourced to peer-reviewed surgical literature and American Society of Plastic Surgeons data. No AI-generated patient photos. No surgeon directory, no paid placements — editorial guidance only.

Five procedures.
One honest reference.
Most patients reach AfterLoss researching one specific procedure. Each hub covers the full picture: candidacy, recovery, cost ranges by state, and how to vet a surgeon — every cost figure sourced and cited.
The Medvi era
made this site necessary.
In February 2026 the FDA issued Warning Letter #721455 to Medvi, a telehealth company that had built $401M in first-year revenue selling compounded GLP-1 medications through 800-plus AI-generated fake doctor profiles and deepfaked patient before-and-after photos. The story made the front page of the New York Times before Techdirt and Futurism unraveled the playbook.
The Medvi case is the cautionary tale this site exists to differentiate against. AfterLoss Atlas is built on the opposite method: every cost figure cites the American Society of Plastic Surgeons or peer-reviewed surgical literature, and any figure not yet individually verified is flagged as such on the page. Every clinical claim is drawn from the published literature, not invented — and the site uses no AI-generated patient photos, no stock imagery posing as patients, and no before-and-after photos it cannot source to a consenting patient.
The same standard governs how AfterLoss treats surgeons. The site does not run a directory, sell premium placement, or route patient leads for a fee — it is editorial guidance, not a marketplace. It teaches the verification a patient should do firsthand: confirm ABPS board certification on the public registry, check that the surgical facility is accredited, and treat the parallel "board-certified in cosmetic surgery" credential as the different, not-equivalent thing it is.
If you spot an error, email [email protected]. We log every correction with the source.
What is AfterLoss Atlas for?
AfterLoss Atlas is the editorial reference for body contouring after GLP-1 medication or bariatric surgery in 2026. Every page cites the American Society of Plastic Surgeons, peer-reviewed surgical literature, and FDA labels, and flags any figure not yet individually verified. It is editorially independent of compounding pharmacies and telehealth brands, and it sells nothing — no surgeon listings, no lead routing, no paid placement.
Pick your procedure. Read your hub. Then talk to a surgeon.
Most patients overspend or under-research because they consult before they understand the framework. Twenty minutes in the atlas saves a re-consult.